Market Overview:
The global thromboelastography (TEG) machine market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, technological advancements in TEG machines, and rising demand for point-of-care testing. However, the high cost of TEG machines may restrain the growth of this market to some extent. Based on type, the global thromboelastography (TEG) machine market can be segmented into single channel and double channel TEG machines, four channels TEG machines, and others. The single channel and double channel segments are expected to account for a major share of the global TEG machine market during the forecast period owing to their low cost and easy availability. Based on application, hospitals are expected to account for a major share of the global TEEG machine market duringthe forecast period owingto their large patient population baseand growing demand for point-of-care testing.
 Machine Industry Outlook.svg)
Product Definition:
A thromboelastography machine is a device used to measure the viscoelasticity and clot formation of blood. This information can be used to help diagnose and treat conditions such as stroke, deep vein thrombosis, and pulmonary embolism. The importance of this machine is that it can provide information about how well a patient's blood clots, which can help doctors determine the best course of treatment.
Single and Double Channel:
Single channel thromboelastography (SCTh) and double channel thromboelastography (DCTh) are two different techniques used for measuring the platelet aggregation. Single Channel Thromboelastography (SCTh) measures only one type of platelet, whereas Double Channel Thromboelastography (DCTh) measures both types of platelets; single cells as well as aggregated ones.
Four Channels:
The four channels are used to measure the volume of blood in a given time interval. It is one of the most important and commonly used methods for measuring coagulation factor levels in plasma and serum. The method uses an automated machine that consists of four glass tubes connected by rubber hoses, which can be inserted into a patient’s arm or leg.
Application Insights:
The others application segment includes research institutes and diagnostic centers. The use of thromboelastography machines in these settings is expected to witness a rise as they provide accurate results in less time. TEG allows the easy measurement of blood coagulation, which helps determine the extent of various disorders including deep vein thrombosis (DVT) and pulmonary embolism (PE). As DVT is one of the most common injuries caused by PE, it has been found that majority of patients with PE are diagnosed through clinical symptoms rather than physical examination findings. Thus, increasing incidence rate for VTEs will help increase demand for TEG over the forecast period.
In addition, hospitals accounted for more than two-third share in global revenue due to factors such as favorable reimbursement policies towards healthcare providers and availability of advanced healthcare facilities equipped with state-of-the-art technology such as tourniquets.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and increasing healthcare expenditure in this region. Moreover, favorable reimbursement policies are also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare spending by governments and private organizations as well as growing awareness about thromboelastography machine among patients. In addition, an increase in patient pool suffering from deep vein thrombosis (DVT) or pulmonary embolism (PE) is also expected to boost demand for these machines over the next eight years.
Major companies include Abbott; Siemens; Philips Healthcare; GE Healthcare Medical Systems & Services Co.
Growth Factors:
- Increasing incidence of thrombotic disorders: The global incidence of thrombotic disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and dietary habits, growing aging population, and rising prevalence of chronic diseases. This is expected to drive the demand for TEG machines in the coming years.
- Technological advancements: The TEG machine market is witnessing rapid technological advancements, with new products being launched regularly. This is helping to improve the accuracy and efficiency of TEG machines, which is resulting in an increase in their adoption rates worldwide.
- Growing awareness about thromboelastography: There has been a growing awareness about thromboelastography among healthcare professionals as well as patients in recent years. This has led to an increase in demand for TEG machines for diagnosis and treatment purposes across the globe.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thromboelastography (TEG) Machine Market Research Report
By Type
Single and Double Channel, Four Channels, Others
By Application
Hospitals, Maternal and Child Health Service, Laboratory, Others
By Companies
Haemonetics, Lepu Technology, Biomart, Medcaptain, Ud-bio, Chongqing Nanfang, WITEYE, Render, Guizhou Jinjiu Biotech, Chongqing Dingrun, Zhejiang Shengyu, Bio-zircon, WerfenLife, Framar Hemologix srl, Sienco
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Thromboelastography (TEG) Machine Market Report Segments:
The global Thromboelastography (TEG) Machine market is segmented on the basis of:
Types
Single and Double Channel, Four Channels, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Maternal and Child Health Service, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haemonetics
- Lepu Technology
- Biomart
- Medcaptain
- Ud-bio
- Chongqing Nanfang
- WITEYE
- Render
- Guizhou Jinjiu Biotech
- Chongqing Dingrun
- Zhejiang Shengyu
- Bio-zircon
- WerfenLife
- Framar Hemologix srl
- Sienco
 Machine Market Overview.svg)
Highlights of The Thromboelastography (TEG) Machine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single and Double Channel
- Four Channels
- Others
- By Application:
- Hospitals
- Maternal and Child Health Service
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thromboelastography (TEG) Machine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Machine Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thromboelastography (TEG) machine is a medical device that measures the thrombus formation in blood vessels. This helps to diagnose and monitor the risk of heart attack or stroke.
Some of the key players operating in the thromboelastography (teg) machine market are Haemonetics, Lepu Technology, Biomart, Medcaptain, Ud-bio, Chongqing Nanfang, WITEYE, Render, Guizhou Jinjiu Biotech, Chongqing Dingrun, Zhejiang Shengyu, Bio-zircon, WerfenLife, Framar Hemologix srl, Sienco.
The thromboelastography (teg) machine market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thromboelastography (TEG) Machine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thromboelastography (TEG) Machine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thromboelastography (TEG) Machine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thromboelastography (TEG) Machine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thromboelastography (TEG) Machine Market Size & Forecast, 2020-2028
4.5.1 Thromboelastography (TEG) Machine Market Size and Y-o-Y Growth
4.5.2 Thromboelastography (TEG) Machine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Single and Double Channel
5.2.2 Four Channels
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Maternal and Child Health Service
6.2.3 Laboratory
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thromboelastography (TEG) Machine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thromboelastography (TEG) Machine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Single and Double Channel
9.6.2 Four Channels
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Maternal and Child Health Service
9.10.3 Laboratory
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Single and Double Channel
10.6.2 Four Channels
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Maternal and Child Health Service
10.10.3 Laboratory
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Single and Double Channel
11.6.2 Four Channels
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Maternal and Child Health Service
11.10.3 Laboratory
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Single and Double Channel
12.6.2 Four Channels
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Maternal and Child Health Service
12.10.3 Laboratory
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Single and Double Channel
13.6.2 Four Channels
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Maternal and Child Health Service
13.10.3 Laboratory
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thromboelastography (TEG) Machine Market: Competitive Dashboard
14.2 Global Thromboelastography (TEG) Machine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics
14.3.2 Lepu Technology
14.3.3 Biomart
14.3.4 Medcaptain
14.3.5 Ud-bio
14.3.6 Chongqing Nanfang
14.3.7 WITEYE
14.3.8 Render
14.3.9 Guizhou Jinjiu Biotech
14.3.10 Chongqing Dingrun
14.3.11 Zhejiang Shengyu
14.3.12 Bio-zircon
14.3.13 WerfenLife
14.3.14 Framar Hemologix srl
14.3.15 Sienco
